Home › Eczema › California › Los Angeles
Eczema clinical trials in Los Angeles, CA
5 studies for Eczema are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
RecruitingPhase 2
- Metropolis Dermatology - DTLA, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 23, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- California Allergy and Asthma Medical Group, Los Angeles
About Eczema
Eczema is a general term for different types of rashes. Atopic dermatitis, the most common type, is an allergic skin reaction. Read about treatments.
More about Eczema on MedlinePlus
Eczema trials in other cities
- San Antonio, TX7 studies
- Birmingham, AL6 studies
- Indianapolis, IN5 studies
- New York City, NY5 studies
- San Diego, CA5 studies
- Miami, FL4 studies
- Phoenix, AZ4 studies
- Santa Clarita, CA4 studies
- Huntington Beach, CA4 studies
- Pittsburgh, PA4 studies
- Washington, DC4 studies
- San Francisco, CA3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.